Luprovian 3.75 mg Injection Combipack Substitute

Substitutes of Luprovian 3.75 mg Injection Combipack meet the same safety and efficacy standards as Luprovian 3.75 mg Injection Combipack, but small differences in absorption or formulation can exist. A doctor can help you choose the right one for your needs.

Yes. Substitutes of Luprovian 3.75 mg Injection Combipack may vary in color, size, or shape due to differences in manufacturing and branding, but this does not affect how they work.

Yes, it’s generally safe to switch between multiple substitutes of Luprovian 3.75 mg Injection Combipack if they have the same salt and strength. However, always inform your doctor so they can monitor how your body responds.

Yes, many people safely use substitutes of Luprovian 3.75 mg Injection Combipack for long-term treatment. Just ensure it’s done under medical supervision.

If your symptoms stay under control or lab results remain stable, the substitute for Luprovian 3.75 mg Injection Combipack is likely working well. Regular follow-ups with your doctor are important.

Absolutely. Even with the same salt, small differences can affect how your body responds when switching from Luprovian 3.75 mg Injection Combipack to its substitute. Always consult your doctor before switching.

Luprovian 3.75 mg Injection Combipack contains Leuprorelin, a synthetic hormone that works similar to the natural hormone, gonadotropin-releasing hormone (GnRH) by acting on the pituitary gland and decreases the levels of testosterone in men and oestrogen in women. Thereby, Luprovian 3.75 mg Injection Combipack is used in the treatment of prostate cancer by inhibiting the growth of tumour or causing it to shrink.

Luprovian 3.75 mg Injection Combipack may stop menstrual periods. However, after 7 to 12 weeks of taking the final dose of injection, periods will resume. Please consult a doctor if you have any concerns regarding this.

Luprovian 3.75 mg Injection Combipack should be used with caution in diabetic patients as it may increase the risk of high blood sugar levels. Therefore, it is advised to regularly monitor blood sugar levels while taking Luprovian 3.75 mg Injection Combipack and inform your doctor if you have diabetes before taking Luprovian 3.75 mg Injection Combipack.

Luprovian 3.75 mg Injection Combipack may be used to treat endometriosis (tissue lining the uterus known as endometrium grows outside the uterus). Luprovian 3.75 mg Injection Combipack reduces oestrogen levels and causes menopause temporarily. Thereby, shrink the tissue outside the uterus or stop its growth.

Luprovian 3.75 mg Injection Combipack may decrease bone density, especially when used for the treatment of premature puberty in children. Therefore, regular monitoring of bone density is recommended while taking Luprovian 3.75 mg Injection Combipack.

Luprovian 3.75 mg Injection Combipack should be used with extreme caution in patients suffering from depression as it may worsen the condition. Therefore, inform your doctor if you have any history of depression before taking Luprovian 3.75 mg Injection Combipack.

No, Luprovian 3.75 mg Injection Combipack is not a chemotherapy medicine. It is a synthetic hormone which belongs to the class of medicines called gonadotropin-releasing hormone (GnRH) agonists.

Yes, Luprovian 3.75 mg Injection Combipack is a hormonal medicine that works by altering reproductive hormones. It is not recommended for use during pregnancy as it can harm the fetus and may lead to abortion. If you are pregnant or planning to become pregnant, please inform your doctor.

The common side effects of Luprovian 3.75 mg Injection Combipack are pain, redness, swelling, or skin hardening at the injection site, muscle weakness, bone pain, inability to have an erection, breast tenderness, headache, vaginal dryness, changes in breast size, acne, or mood swings. If any of these side effects persist or worsen, please consult your doctor.

Luprovian 3.75 mg Injection Combipack belongs to the class of synthetic hormones used in the treatment of prostate cancer in men, endometriosis, and hormone-responsive breast cancer in women. Also, it is used to treat premature puberty in children.